Abstract:Importance: Physical activity guidelines are predominantly based on questionnaire-based studies measuring only longer planned physical activity bouts (>10-15 continuous minutes). To date, short intermittent bouts of physical activity that may be beneficial for health ('micropatterns'), have counted very little towards physical activity guidelines (currently 150-300 minutes of moderate or 75-150 minutes of vigorous intensity activity per week). Objective: We examined all-cause and cardiovascular disease (CVD) mortality associations of wearable device-captured activity accumulated through intermittent moderate to vigorous (IMVPA; ≤3 min) and vigorous (IVPA; ≤1 min) intensity bouts, by guideline adherence for a) active adults (eg. doing at least 150 mins/wk of moderate or 75 mins/wk of vigorous intensity physical activity), and b) inactive adults (not meeting the above amounts). Design: Prospective cohort study Setting: UK Biobank Participants: 62,899 adults (mean age 61 years, 55.7% female) with wrist-worn accelerometer data, followed up for an average of 8.0 (SD= 0.9) years Exposures: Intermittent moderate-vigorous (IMVPA; ≤3 min) and vigorous (IVPA; ≤1 min) intensity bouts; stratified by participants meeting and not meeting physical activity guidelines. Main outcomes and measures: All-cause and CVD mortality obtained through linkage with the National Health Service (NHS) Digital of England and Wales or the NHS Central Register and National Records of Scotland. Cox restricted cubic spline regression were used to assess the dose-response associations. Results: There were 1,583 all-cause and 442 CVD deaths among 62,899 adults (mean age 61 years, 55.7% female). Micropatterns accrued IMVPA and IVPA showed linear beneficial dose response associations in both the inactive and active groups. We observed a 1.4 to 2.0-fold lower mortality risk among inactive compared to active adults. For all-cause mortality, a median 4.0 minutes/day of IVPA was associated with a hazard ratio (HR) of 0.40 [0.32, 0.52] in inactive adults and 0.74 [0.58, 0.95] in active adults, compared to not doing any IVPA. For CVD mortality, a median of 13.0 minutes/day of IMVPA was associated with an HR of 0.32 [0.22, 0.51] in inactive adults and 0.53 [0.37, 0.78] in active adults. Analogous patterns of dose-response were present when adherence to guidelines was assessed using questionnaire-based data that only considered continuous activity bouts lasting at least 10 minutes. Conclusions and relevance: Among participants not meeting guidelines, intermittent moderate-vigorous physical activity showed stronger beneficial dose-response association with all-cause and CVD mortality, compared to active adults, highlighting potential health benefits from brief activity bursts for less active adults. Considering such activity patterns are hardly represented in the evidence used to develop current guidelines, our findings support the transition of future guidelines towards wearables-informed evidence.

Intensity-specific physical activity measured by accelerometer and the risk of mortality among individuals with cardiometabolic diseases: A prospective study from the UK Biobank

Association of accelerometer-derived physical activity with all-cause and cause-specific mortality among individuals with cardiovascular diseases: A prospective cohort study

The Impact of Physical Activity Intensity on the Dynamic Progression of Cardiometabolic Multimorbidity: Prospective Cohort Study Using UK Biobank Data.

Interplay between physical activity volume and intensity with modeled life expectancy in women and men: A prospective cohort analysis

Quantifying the Predictive Performance of Objectively Measured Physical Activity on Mortality in the UK Biobank

Association of Physical Activity Volume and Intensity with Incident Cardiovascular Disease: a UK Biobank Study

Correction: Diurnal Patterns of Accelerometer-Measured Physical Activity and Sleep and Risk of All-Cause Mortality: a Follow-Up of the National Health and Nutrition Examination Surveys (NHANES)

Wearable accelerometer-derived physical activity and incident disease

Accelerometer-derived physical activity and mortality in individuals with type 2 diabetes

Abstract 13759: Adherence to Healthy Lifestyle is Associated with Lower Total and Cause-Specific Mortality Risk among Patients with Diabetes: the UK Biobank Study

Joint association of physical activity and sleep duration with risk of all-cause and cause-specific mortality: a population-based cohort study using accelerometry

Micropatterns of physical activity in relation to all-cause and cardiovascular disease mortality: the stealth lifestyle factor?

Joint Associations of Diet and Device-measured Physical Activity with Mortality and Incident CVD and Cancer: a prospective analysis of the UK Biobank Study

Associations of adiposity and device-measured physical activity with cancer incidence: UK Biobank prospective cohort study

Associations of timing of physical activity with all-cause and cause-specific mortality in a prospective cohort study

Dose-response association of an accelerometer-measured physical activity with all-cause mortality and cardiovascular disease incidence: Prospective cohort with 76,074 participants

Device-measured sedentary time and intensity-specific physical activity in relation to all-cause and cardiovascular disease mortality: the UK Biobank cohort study

Does Objectively Measured Light-Intensity Physical Activity Reduce The Risk Of Cardiovascular Mortality? A Meta-Analysis

Time-Varying Effect of Physical Activity on Mortality Among Myocardial Infarction Survivors: A Nationwide Population-Based Cohort Study

ASSOCIATIONS OF RELATIVE INTENSITY OF PHYSICAL ACTIVITY WITH INCIDENT CARDIOVASCULAR OUTCOMES AND MORTALITY

Ideal 24-h physical activity trajectory reduces all-cause, cause-specific mortality and cardiovascular outcomes through aging deceleration and inflammation regulation: A UK biobank study